Despite advances in surgical intervention, radiotherapy, and multimodal treatments, lung cancer incidence continues to rise, and GRPR overexpression is found in 68% of adenocarcinoma cases in NSCLC [38,39]. This evidence concerns the gene GRPR and non-small cell lung carcinoma.